ResMed Inc. (NYSE:RMD) Plans Quarterly Dividend of $0.60

Key Points

• ResMed declared a quarterly dividend of $0.60 per share (annualized $2.40) with a record/ex-dividend date of May 14 and a payment date of June 18, implying a yield of about 1.2%.
• The company has increased its dividend for 13 consecutive years, has averaged a 0.1% annual raise over the last three years, and carries a low payout ratio (~22.7%), with analysts expecting earnings strong enough to reduce the payout ratio to about 19.8% next year.
• ResMed beat expectations for the quarter, reporting $2.86 EPS vs. $2.79 expected and revenue of $1.43 billion (up 10.8% YoY), with a net margin of 27.53% and ROE of 25.2%.

ResMed Inc. (NYSE:RMD - Get Free Report) declared a quarterly dividend on Thursday, April 30th. Investors of record on Thursday, May 14th will be paid a dividend of 0.60 per share by the medical equipment provider on Thursday, June 18th. This represents a c) annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Thursday, May 14th.

ResMed has raised its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 13 consecutive years. ResMed has a payout ratio of 22.7% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect ResMed to earn $12.10 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 19.8%.

ResMed Price Performance

Shares of RMD opened at $199.47 on Friday. ResMed has a fifty-two week low of $209.30 and a fifty-two week high of $293.81. The firm's 50-day simple moving average is $233.35 and its two-hundred day simple moving average is $246.69. The stock has a market cap of $29.06 billion, a PE ratio of 19.93, a price-to-earnings-growth ratio of 1.40 and a beta of 0.93. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.32 and a current ratio of 3.06.

ResMed (NYSE:RMD - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $2.86 EPS for the quarter, beating the consensus estimate of $2.79 by $0.07. ResMed had a net margin of 27.53% and a return on equity of 25.20%. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same period in the prior year, the firm posted $2.37 EPS. ResMed's revenue for the quarter was up 10.8% on a year-over-year basis. Analysts anticipate that ResMed will post 11.05 earnings per share for the current fiscal year.

About ResMed

ResMed NYSE: RMD is a global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions. Founded in 1989, the company is headquartered in San Diego, California, and develops, manufactures and distributes a range of devices and software used by patients, clinicians and providers worldwide.

ResMed's product portfolio centers on noninvasive ventilation and sleep therapy equipment, including continuous positive airway pressure (CPAP) and bilevel devices, masks and related accessories for the treatment of obstructive sleep apnea and other respiratory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.